Febuxostat Is a Novel Drug in Therapy for Gout

Nauchno-Prakticheskaya Revmatologiya - Russian Federation
doi 10.14412/1995-4484-2011-603
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Febuxostat in the Therapy of Gout: From Theory to Practice

Modern Rheumatology Journal
2017English

Febuxostat Treatment for Gout: What the Clinician Needs to Know

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2009English

Febuxostat: The Evidence for Its Use in the Treatment of Hyperuricemia and Gout

Core Evidence
MedicineReviewsReferencesPharmacology
2009English

Febuxostat for the Treatment of Chronic Tophaceous Gout in a Patient on Continuous Ambulatory Peritoneal Dialysis

The Korean Journal of Medicine
2015English

Therapy With Canakinumab for Gout

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2019English

The Future of Febuxostat After the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities (CARES) Trial: Who CARES?

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2018English

Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Troxis Necrosis, a Novel Mechanism for Drug-Induced Hepatitis Secondary to Immunomodulatory Therapy

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2015English

Baseline Urate Level and Renal Function Predict Outcomes of Urate-Lowering Therapy Using Low Doses of Febuxostat and Benzbromarone: A Prospective, Randomized Controlled Study in a Chinese Primary Gout Cohort

Arthritis Research & Therapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy